Paul Carroll

Dr. Paul Carroll


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2018 in Foot & Ankle Specialist
Verified
Journal Article
Closed access
PCPaul Carroll
Paul Carroll
RHRobert M. Henshaw
Robert M. Henshaw
CGCaitlin Garwood
Caitlin Garwood
KRKatherine Raspovic
Katherine Raspovic
DKDhruv Kumar
Dhruv Kumar
Plantar fibromatosis (morbus Ledderhose), an extra-abdominal desmoid tumor of the plantar foot, is a rare benign hyperproliferative disorder of the plantar fascia with an unknown etiology. The main clinical characteristics include slow growing nodules on the medial and central bands of the plantar fascia, which may become painful and negatively affect ambulation. Most established conservative therapies today target symptomatic relief. As symptoms progress, therapies such as injections, shockwave ablation, radiation, and/or surgery may be required. This review aims to provide insight into the pathophysiology of this condition in addition to detailing current and investigational therapies for this disorder. Many therapies have been proven in similar conditions, which could lead to promising treatment options for plantar fibromatosis. Levels of Evidence: Level V: Expert opinion

13 July 2026 in Foot & Ankle Surgery: Techniques, Reports & Cases
Verified
Journal Article
Open access
ADAlex Dang
Alex Dang
HBHarsh Bhavsar
Harsh Bhavsar
PCPaul Carroll
Paul Carroll
RWRex Wei–Hung
Rex Wei–Hung

12 June 2026 in Foot & Ankle Surgery: Techniques, Reports & Cases
Verified
Journal Article
Open access
JSJered M. Stowers
Jered M. Stowers
ABAlexandra T. Black
Alexandra T. Black
ADAlex Dang
Alex Dang
SCSibella Campbell
Sibella Campbell
PCPaul Carroll
Paul Carroll

6 September 2026 in Foot & Ankle Surgery: Techniques, Reports & Cases
Verified
Journal Article
Open access
PKPatrick Kagel
Patrick Kagel
VAVarsha Atuluru
Varsha Atuluru
THTimothy Hoffmeister
Timothy Hoffmeister
PCPaul Carroll
Paul Carroll

26 October 2026 in Annals of Vascular Surgery - Brief Reports and Innovations
Verified
Journal Article
Open access
PCPaul Carroll
Paul Carroll
JMJohn Miller
John Miller
MKMarian R. Kavanaugh
Marian R. Kavanaugh
HPHarsh Patel
Harsh Patel
JAJayson Nicholas Atves
Jayson Nicholas Atves
RHRex W. Hung
Rex W. Hung

6 February 2026 in Clinics and Practice
Verified
Journal Article
Open access
PDF file
PCPaul Carroll
Paul Carroll
ABAlyson Boudreau
Alyson Boudreau
HHHaoning Hu
Haoning Hu
RLRyan P. Lin
Ryan P. Lin
BLBilal Louzati
Bilal Louzati
EDEddie Davis
Eddie Davis
Background: Ledderhose Disease, or plantar fibromatosis, is a fibroproliferative disorder affecting the plantar fascia with limited effective treatment options. Although hyaluronidase has a long history of clinical use, it has not been previously used for Ledderhose Disease. This study explores the use of combined hyaluronidase and triamcinolone acetonide enzymatic injections as a novel and promising technique for managing Ledderhose Disease. Methods: This paper investigates the use of combination therapy with hyaluronidase, triamcinolone acetonide, and lidocaine injections in three patients with Ledderhose Disease. Injection protocols, dosage, frequency, and patient outcomes are all discussed. Additionally, this study explores the underlying mechanisms of hyaluronidase action in Ledderhose Disease, shedding light on its potential to modulate fibrotic tissue and alleviate symptoms. Results: All three patients treated with a series of hyaluronidase, triamcinolone acetonide, and lidocaine anesthetic injections experienced either a significant reduction in or elimination of nodules and associated pain within 6 weeks after initial injection. Patients were asymptomatic at two years follow-up after injections. Conclusions: The combination of hyaluronidase and triamcinolone acetonide injections significantly decreased pain and softened fibromas faster than triamcinolone acetonide injection alone, as explored in previous studies. Large prospective studies are needed to further compare enzymatic injection therapies in the management of Ledderhose Disease.